Triamcinolone Assisted Anterior Vitrectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

February 29, 2008

Study Completion Date

June 30, 2008

Conditions
VitrectomyCataract
Interventions
DRUG

Intra ocular injection of triamcinolone acetonide

In all patients triamcinolone acetonide was prepared by keeping the bottle vertical to allow sedimentation of crystals thus removing the vehicle. It was then injected into the anterior chamber (2 ml with concentration 20 mg/ml) just prior to anterior vitrectomy. The direction of the tip of the needle was kept away from the corneal endothelium to minimize endothelial toxicity. Triamcinolone was removed as quickly \& completely as possible after finishing anterior vitrectomy

Trial Locations (2)

11371

El-Nour Eye hospital, Cairo

11451

Kasr Al-Ainy Hospital Cairo university, Cairo

All Listed Sponsors
collaborator

AL-Nour Eye Hospital

OTHER

collaborator

Kasr El Aini Hospital

OTHER

lead

Cairo University

OTHER

NCT01051648 - Triamcinolone Assisted Anterior Vitrectomy | Biotech Hunter | Biotech Hunter